Market Snapshot: Dow rises to start Oct and Q4 as Merck reports success in COVID antiviral drug trial, but Nasdaq weighed by tech weakness


U.S. stock benchmarks rise Friday morning to kick off the start of the final quarter of the year, following heavy selling that closed a bruising September for investors.

Europe Markets: Bank of America turns bearish on European stocks, sees ‘anti-goldilocks’ shift ahead

Previous article

Economic Report: Consumers boost spending again, but they’re paying higher prices due to high U.S. inflation

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News